Search for: "Federal Trade Commission v. Lundbeck Inc."
Results 1 - 16
of 16
Sorted by Relevance
|
Sort by Date
1 Oct 2010, 5:25 am
In many ways, it's surprising that the Federal Trade Commission and the State of Minnesota were able to pursue the lawsuit in the first place, given the efforts undertaken by the Supreme Court to dismantle the century-old antitrust laws in this country. [read post]
19 Aug 2011, 9:08 am
” Filed under: antitrust, federal trade commission, merger guidelines, mergers & acquisitions [read post]
24 Aug 2011, 8:12 am
The August 19 decision in Federal Trade Commission v. [read post]
17 Apr 2009, 12:00 am
Ltd. sues 11 generics companies over Levaquin patents (Law 360) Lexapro (Escitalopram) – Netherlands District court invalidates Lundbeck’s patent EP ‘066 (IPKat) Lexapro (Escitalopram) - Baldwin’s rules explained (The SPC Blog) Lexapro (Escitalopram) – federal district Judge agrees to determine whether Forest Laboratories destroyed key documents (Law 360) Pegasys (PEG interferon alfa 2a) – Roche wins post grant opposition… [read post]
11 May 2011, 4:54 am
Highlights this week included: US: Federal Trade Commission issues report on reverse settlement agreements in FY2010 (Patent Docs) (Orange Book Blog) (FDA Law Blog) US: Billups-Rothenberg v. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
30 Nov 2009, 12:00 am
Stichting de Thuiskopie v Opus Supplies Deutschland GmbH(The 1709 Copyright Blog) ECJ: upholds ‘compulsory licences’ of Green Dot trade mark: Der Grüne Punkt-Duales System Deutschland GmbH v European Commission (JIPLP) ECJ: Manifest inadmissibility of reference for preliminary ruling in Canon Kabushiki Kaisha (C-181/09) (Class 46) (IPKat) Bud court asks ECJ: what is ‘acquiesced’? [read post]
16 Jan 2009, 7:00 am
(IP finance) Global - Copyright A bit about derivative works (Ip's What's Up) Australia Singapore Treaty takes effect March 2009 (Australian Trade Marks Law Blog) Capital allowances: business related costs – business transfer arrangement establishing right to intellectual property (IP Down Under) Droit de suite scheme introduced into Parliament (International Law Office) Interlocutory relief partially granted in Sebel Furniture Limited… [read post]
1 Jul 2009, 7:14 am
OHIM decision in Laboratorios Andrómaco, S.A. v OTC Pharma International B V (Class 46) India: Valgancyclovir hearings and the need for more transparency: Roche v Cipla (Spicy IP) Japan approves first follow-on biologic (Patent Docs) UK: Journal of Intellectual Property Law & Practice note on ‘Paediatric extensions: the requirement of a compliance statement’ on UK IPO decision in Merck and Co, Inc (The SPC Blog) US: Sen… [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
27 Aug 2011, 4:34 am
http://j.st/SUL Federal Trade Commission v. [read post]
18 Apr 2008, 2:00 am
– ownership of IP: (Dilanchian), Consultant or contractor IP: (Dilanchian), IP and general business law issues: Website terms of use reduce risk: (Dilanchian), Plant breeder’s rights actions in the Federal Court will now be regarded as IP cases for the purpose of docket allocation: (IPwar’s), Ajinomoto v NutraSweet – inventive step and costs: (IPRoo), Australian Federation Against Copyright Theft 2020 submission:… [read post]
2 May 2008, 7:00 am
Landmark IP implications for universities: University of Western Australia v Gray: (IPRoo), (Managing Intellectual Property), (The Age), Domain name transfer made easier: (Australian Trade Marks Law Blog), Quantum of obviousness in Australian patent laws - C Lawson: (IP Down Under), Separating Sony sheep from Grokster (and Kazaa) goats: Reckoning [read post]
29 Aug 2008, 1:25 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC sets strict standards to establish inequitable conduct: Star Scientific v R J Reynolds Tobacco: (Hal Wegner), (Maryland Intellectual Property Law Blog), (Patent Prospector), (Patent Docs), (Patently-O), (more from Patently-O), (Philip Brooks), (Law360), (I/P Updates), Safe harbour ruling in Io v Veoh could help YouTube in Viacom… [read post]
19 Sep 2018, 11:28 am
Though the complaint was unanimously approved by a Republican-led Federal Trade Commission, and the agency based its case on the testimony of one of the nation’s most prominent conservative economists, Judge Kavanaugh thought it would “turn back the clock” to the “the bad old days when mergers were viewed with suspicion regardless of their economic benefits. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its… [read post]
